➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Merck
Moodys
Boehringer Ingelheim
Harvard Business School

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Tosedostat

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Tosedostat?

Tosedostat is an investigational drug.

There have been 11 clinical trials for Tosedostat. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2012.

The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Chroma Therapeutics, CTI BioPharma, and Fred Hutchinson Cancer Research Center.

There is one US patent protecting this investigational drug and seven international patents.

Recent Clinical Trials for Tosedostat
TitleSponsorPhase
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic AdenocarcinomaWashington University School of MedicinePhase 1/Phase 2
Study of Clinical Efficacy and Safety of Tosedostat in MDSCTI BioPharmaPhase 2
Study of Clinical Efficacy and Safety of Tosedostat in MDSWeill Medical College of Cornell UniversityPhase 2

See all Tosedostat clinical trials

Clinical Trial Summary for Tosedostat

Top disease conditions for Tosedostat
Top clinical trial sponsors for Tosedostat

See all Tosedostat clinical trials

International Patents for Tosedostat

Drugname Country Document Number Estimated Expiration Related US Patent
Tosedostat Austria AT299701 2019-01-29   Start Trial
Tosedostat Australia AU2118900 2019-01-29   Start Trial
Tosedostat Germany DE60021347 2019-01-29   Start Trial
Tosedostat European Patent Office EP1146867 2019-01-29   Start Trial
Tosedostat United Kingdom GB9901863 2019-01-29   Start Trial
Tosedostat Japan JP2002535362 2019-01-29   Start Trial
Tosedostat World Intellectual Property Organization (WIPO) WO0044373 2019-01-29   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Merck
Moodys
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.